Newsbenzinga
Arcutis Biotherapeutics’ Subsidiary Arcutis Canada Secures Health Canada Approval For Roflumilast Cream In Pediatric Atopic Dermatitis Patients
· Published
Article summary
Please check the source for details.
An excerpt from the original article.
Comments —
Loading comments…